840887C

22:6 PA

1,2-didocosahexaenoyl-sn-glycero-3-phosphate (sodium salt), chloroform

• 동의어(들): 1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphate (sodium salt); PA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
• 실험식(Hill 표기법): C₄₇H₆₈O₈PNa
• CAS Number: 474943-34-5
• Molecular Weight: 815.00
• UNSPSC 코드: 51191904
• NACRES: NA.25

속성

• 분석: >99% (TLC)
• 형태: liquid
• 포장: pkg of 1 × 2.5 mL (840887C-25mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand 840887C
• 농도: 10 mg/mL (840887C-25mg)
• 지질 유형: cardiolipins; phospholipids
• 배송 상태: dry ice
• 저장 온도: −20°C
• SMILES string: [H][C@@](COP([O-])(O)=O)(OC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)COC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O.[Na+]
• InChI: 1S/C47H69O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-46(48)53-43-45(44-54-56(50,51)52)55-47(49)42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h5-8,11-14,17-20,23-26,29-32,35-38,45H,3-4,9-10,15-16,21-22,27-28,33-34,39-44H2,1-2H3,(H2,50,51,52);/q;+1/p-1/b7-5-,8-6-,13-11-,14-12-,19-17-,20-18-,25-23-,26-24-,31-29-,32-30-,37-35-,38-36-;/t45-;/m1./s1
• InChI key: ZRYYQXRGXSHOSJ-GKSUZLNLSA-M

설명

일반 설명

22:6 PA or 1,2-didocosahexaenoyl-sn-glycero-3-phosphate (sodium salt) is a sodium salt of phosphatidic acid, with substitution of two chains of docosahexaenic acid at the sn-1 and sn-2 positions, in the glycerol backbone.

애플리케이션

22:6 PA or 1,2-didocosahexaenoyl-sn-glycero-3-phosphate (sodium salt) has been used as an internal standard in shotgun electrospray ionization tandem mass spectrometry (ESI-MS/MS) for the analysis of phospholipids.

포장

5 mL Clear Glass Sealed Ampule (840887C-25mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• 픽토그램: GHS06,GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H302,H315,H319,H331,H336,H351,H361d,H372
• 예방조치 성명서: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 표적 기관: Central nervous system
• WGK: WGK 3